{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T06:02:07Z","timestamp":1792735327571,"version":"4.5.0"},"reference-count":182,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/ajp.0b013e31816b2f43","type":"journal-article","created":{"date-parts":[[2008,6,16]],"date-time":"2008-06-16T07:05:40Z","timestamp":1213599940000},"page":"479-496","source":"Crossref","is-referenced-by-count":500,"title":["Opioid-induced Hyperalgesia in Humans"],"prefix":"10.1097","volume":"24","author":[{"given":"Larry F.","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin S.","family":"Angst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210204","first-page":"17","article-title":"The history of poppy and of opium and their expansion in antiquity","volume":"3","author":"Krjtikos","year":"1967","journal-title":"Bull Narc"},{"key":"R2-3-20210204","article-title":"Achieving Balance in National Opioids Control Policy: Guidelines for Assessment","year":"2000"},{"key":"R3-3-20210204","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1212\/01.WNL.0000057720.36503.2C","article-title":"Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial","volume":"60","author":"Gimbel","year":"2003","journal-title":"Neurology"},{"key":"R4-3-20210204","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1212\/WNL.59.7.1015","article-title":"Opioids versus antidepressants in postherpetic neuralgia: a randomized, placebo-controlled trial","volume":"59","author":"Raja","year":"2002","journal-title":"Neurology"},{"key":"R5-3-20210204","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMoa021420","article-title":"Oral opioid therapy for chronic peripheral and central neuropathic pain","volume":"348","author":"Rowbotham","year":"2003","journal-title":"N Engl J Med"},{"key":"R6-3-20210204","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0304-3959(03)00160-X","article-title":"Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy","volume":"105","author":"Watson","year":"2003","journal-title":"Pain"},{"key":"R7-3-20210204","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0140-6736(96)09024-1","article-title":"Randomised double-blind active-placebo-controlled crossover trial of intravenous fentanyl in neuropathic pain","volume":"349","author":"Dellemijn","year":"1997","journal-title":"Lancet"},{"key":"R8-3-20210204","first-page":"862","article-title":"Treatment of osteoarthritis pain with controlled release oxycodone or fixed combination oxycodone plus acetaminophen added to nonsteroidal antiinflammatory drugs: a double blind, randomized, multicenter, placebo controlled trial","volume":"26","author":"Caldwell","year":"1999","journal-title":"J Rheumatol"},{"key":"R9-3-20210204","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1001\/archinte.160.6.853","article-title":"Around-the-clock, controlled-release oxycodone therapy for osteoarthritis-related pain: placebo-controlled trial and long-term evaluation","volume":"160","author":"Roth","year":"2000","journal-title":"Arch Intern Med"},{"key":"R10-3-20210204","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(96)90339-6","article-title":"Randomised trial of oral morphine for chronic non-cancer pain","volume":"347","author":"Moulin","year":"1996","journal-title":"Lancet"},{"key":"R11-3-20210204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3959(94)00262-D","article-title":"Efficacy of controlled-release codeine in chronic non-malignant pain: a randomized, placebo-controlled clinical trial","volume":"62","author":"Arkinstall","year":"1995","journal-title":"Pain"},{"key":"R12-3-20210204","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.pain.2004.09.019","article-title":"Opioids in chronic non-cancer pain: systematic review of efficacy and safety","volume":"112","author":"Kalso","year":"2004","journal-title":"Pain"},{"key":"R13-3-20210204","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1212\/WNL.65.12_suppl_4.S32","article-title":"Methodological issues in clinical trials of opioids for chronic pain","volume":"65","author":"Katz","year":"2005","journal-title":"Neurology"},{"key":"R14-3-20210204","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1097\/AJP.0b013e31802b582f","article-title":"Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year Registry Study","volume":"23","author":"Portenoy","year":"2007","journal-title":"Clin J Pain"},{"key":"R15-3-20210204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jpain.2005.11.006","article-title":"Opioid prescriptions by U.S. primary care physicians from 1992 to 2001","volume":"7","author":"Olsen","year":"2006","journal-title":"J Pain"},{"key":"R16-3-20210204","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0885-3924(01)00396-7","article-title":"Chronic pain prevalence and analgesic prescribing in a general medical population","volume":"23","author":"Clark","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"R18-3-20210204","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/AJP.0b013e318032de5d","article-title":"How effective is long-term opioid therapy for chronic noncancer pain?","volume":"23","author":"Rowbotham","year":"2007","journal-title":"Clin J Pain"},{"key":"R19-3-20210204","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/00000542-200603000-00025","article-title":"Opioid-induced hyperalgesia: a qualitative systematic review","volume":"104","author":"Angst","year":"2006","journal-title":"Anesthesiology"},{"key":"R20-3-20210204","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11916-006-0011-5","article-title":"Opioid-induced abnormal pain sensitivity","volume":"10","author":"Mao","year":"2006","journal-title":"Curr Pain Headache Rep"},{"key":"R21-3-20210204","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/bip.20254","article-title":"Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure","volume":"80","author":"Ossipov","year":"2005","journal-title":"Biopolymers"},{"key":"R22-3-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00001756-200301200-00001","article-title":"Opioid-induced hyperalgesia: abnormal or normal pain?","volume":"14","author":"Simonnet","year":"2003","journal-title":"Neuroreport"},{"key":"R23-3-20210204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF01637005","article-title":"Ueber die Gewoehnung an Gifte","volume":"21","author":"Rossbach","year":"1880","journal-title":"Pflugers Arch Gesamte Physiol Menschen"},{"key":"R24-3-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0304-3959(01)00306-2","article-title":"Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine","volume":"93","author":"Doverty","year":"2001","journal-title":"Pain"},{"key":"R25-3-20210204","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/0885-3924(94)90203-8","article-title":"Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status","volume":"9","author":"Compton","year":"1994","journal-title":"J Pain Symptom Manage"},{"key":"R26-3-20210204","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0376-8716(00)00200-3","article-title":"Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent","volume":"63","author":"Compton","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"R27-3-20210204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0885-3924(00)00191-3","article-title":"Pain responses in methadone-maintained opioid abusers","volume":"20","author":"Compton","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R28-3-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3959(00)00391-2","article-title":"Hyperalgesic responses in methadone maintenance patients","volume":"90","author":"Doverty","year":"2001","journal-title":"Pain"},{"key":"R29-3-20210204","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0009-9236(99)90090-5","article-title":"Steady-state pharmacokinetics and pharmacodynamics in methadone maintenance patients: comparison of those who do and do not experience withdrawal and concentration-effect relationships","volume":"65","author":"Dyer","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"R30-3-20210204","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-2007-979567","article-title":"Pain perception of intravenous heroin users on maintenance therapy with levomethadone","volume":"29","author":"Schall","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"R31-3-20210204","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1213\/01.ANE.0000078811.80093.88","article-title":"Intravenous remifentanil produces withdrawal hyperalgesia in volunteers with capsaicin-induced hyperalgesia","volume":"97","author":"Hood","year":"2003","journal-title":"Anesth Analg"},{"key":"R32-3-20210204","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0304-3959(03)00276-8","article-title":"Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal","volume":"106","author":"Angst","year":"2003","journal-title":"Pain"},{"key":"R33-3-20210204","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.drugalcdep.2005.09.007","article-title":"Opioids and abnormal pain perception: new evidence from a study of chronic opioid addicts and healthy subjects","volume":"82","author":"Pud","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"R34-3-20210204","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"Am J Psychiatry"},{"key":"R35-3-20210204","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3109\/10673229709030550","article-title":"The self-medication hypothesis of substance use disorders: a reconsideration and recent applications","volume":"4","author":"Khantzian","year":"1997","journal-title":"Harv Rev Psychiatry"},{"key":"R36-3-20210204","article-title":"Cognitive Therapy of Substance Abuse","author":"Beck","year":"1993"},{"key":"R37-3-20210204","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/archpsyc.1973.01750320112017","article-title":"Methadone\u2013a reevaluation","volume":"28","author":"Martin","year":"1973","journal-title":"Arch Gen Psychiatry"},{"key":"R38-3-20210204","doi-asserted-by":"crossref","first-page":"265","DOI":"10.3109\/08990229209144776","article-title":"A psychophysical comparison of sensory and affective responses to four modalities of experimental pain","volume":"9","author":"Rainville","year":"1992","journal-title":"Somatosens Mot Res"},{"key":"R39-3-20210204","first-page":"4","article-title":"Clinical evidence for opioid-induced hyperalgesia.","volume":"10","author":"Hay","year":"2003","journal-title":"Proceedings of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists"},{"key":"R40-3-20210204","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/BF03012978","article-title":"Intraoperative high dose fentanyl induces postoperative fentanyl tolerance","volume":"46","author":"Chia","year":"1999","journal-title":"Can J Anaesth"},{"key":"R41-3-20210204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00000542-200008000-00019","article-title":"Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement","volume":"93","author":"Guignard","year":"2000","journal-title":"Anesthesiology"},{"key":"R42-3-20210204","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bja\/78.3.311","article-title":"Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine?","volume":"78","author":"Cooper","year":"1997","journal-title":"Br J Anaesth"},{"key":"R43-3-20210204","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00000542-200507000-00022","article-title":"Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine","volume":"103","author":"Joly","year":"2005","journal-title":"Anesthesiology"},{"key":"R44-3-20210204","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1093\/bja\/87.6.866","article-title":"No clinical evidence of acute opioid tolerance after remifentanil-based anaesthesia","volume":"87","author":"Cortinez","year":"2001","journal-title":"Br J Anaesth"},{"key":"R45-3-20210204","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1097\/00000542-200502000-00024","article-title":"Intraoperative remifentanil infusion does not increase postoperative opioid consumption compared with 70% nitrous oxide","volume":"102","author":"Lee","year":"2005","journal-title":"Anesthesiology"},{"key":"R46-3-20210204","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1399-6576.2005.00861.x","article-title":"Intra-operative remifentanil might influence pain levels in the immediate post-operative period after major abdominal surgery","volume":"49","author":"Hansen","year":"2005","journal-title":"Acta Anaesthesiol Scand"},{"key":"R47-3-20210204","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/00000542-200611000-00024","article-title":"Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans","volume":"105","author":"Troster","year":"2006","journal-title":"Anesthesiology"},{"key":"R48-3-20210204","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00000542-200108000-00022","article-title":"A new model of electrically evoked pain and hyperalgesia in human skin: the effects of intravenous alfentanil, S(+)-ketamine, and lidocaine","volume":"95","author":"Koppert","year":"2001","journal-title":"Anesthesiology"},{"key":"R49-3-20210204","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00000542-200307000-00025","article-title":"Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans","volume":"99","author":"Koppert","year":"2003","journal-title":"Anesthesiology"},{"key":"R50-3-20210204","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1213\/01.ANE.0000048086.58161.18","article-title":"Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans","volume":"96","author":"Luginbuhl","year":"2003","journal-title":"Anesth Analg"},{"key":"R51-3-20210204","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.pbb.2003.10.017","article-title":"Precipitated opioid withdrawal across acute physical dependence induction methods","volume":"77","author":"Compton","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"R52-3-20210204","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jpain.2003.08.003","article-title":"Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study","volume":"4","author":"Compton","year":"2003","journal-title":"J Pain"},{"key":"R53-3-20210204","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpain.2005.08.001","article-title":"Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study","volume":"7","author":"Chu","year":"2006","journal-title":"J Pain"},{"key":"R54-3-20210204","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1523\/JNEUROSCI.15-12-08031.1995","article-title":"Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal","volume":"15","author":"Aley","year":"1995","journal-title":"J Neurosci"},{"key":"R55-3-20210204","doi-asserted-by":"crossref","first-page":"8018","DOI":"10.1523\/JNEUROSCI.17-20-08018.1997","article-title":"Different mechanisms mediate development and expression of tolerance and dependence for peripheral mu-opioid antinociception in rat","volume":"17","author":"Aley","year":"1997","journal-title":"J Neurosci"},{"key":"R56-3-20210204","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.1523\/JNEUROSCI.17-10-03907.1997","article-title":"Dissociation of tolerance and dependence for opioid peripheral antinociception in rats","volume":"17","author":"Aley","year":"1997","journal-title":"J Neurosci"},{"key":"R57-3-20210204","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1523\/JNEUROSCI.17-02-00735.1997","article-title":"Multiple receptors involved in peripheral alpha 2, mu, and A1 antinociception, tolerance, and withdrawal","volume":"17","author":"Aley","year":"1997","journal-title":"J Neurosci"},{"key":"R58-3-20210204","first-page":"890","article-title":"Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice","volume":"256","author":"Arts","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"R59-3-20210204","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/00000542-200605000-00023","article-title":"A genetic analysis of opioid-induced hyperalgesia in mice","volume":"104","author":"Liang","year":"2006","journal-title":"Anesthesiology"},{"key":"R60-3-20210204","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1523\/JNEUROSCI.14-04-02301.1994","article-title":"Thermal hyperalgesia in association with the development of morphine tolerance in rats: roles of excitatory amino acid receptors and protein kinase C","volume":"14","author":"Mao","year":"1994","journal-title":"J Neurosci"},{"key":"R61-3-20210204","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/S0022-3565(24)37250-7","article-title":"Repetitive opioid abstinence causes progressive hyperalgesia sensitive to N-methyl-D-aspartate receptor blockade in the rat","volume":"284","author":"Dunbar","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"R62-3-20210204","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.1523\/JNEUROSCI.21-11-04074.2001","article-title":"Progressive enhancement of delayed hyperalgesia induced by repeated heroin administration: a sensitization process","volume":"21","author":"Celerier","year":"2001","journal-title":"J Neurosci"},{"key":"R63-3-20210204","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(99)01998-8","article-title":"Evidence for opiate-activated NMDA processes masking opiate analgesia in rats","volume":"847","author":"Celerier","year":"1999","journal-title":"Brain Res"},{"key":"R64-3-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0306-4522(98)00652-6","article-title":"Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity","volume":"89","author":"Laulin","year":"1999","journal-title":"Neuroscience"},{"key":"R65-3-20210204","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1046\/j.1460-9568.1998.00083.x","article-title":"Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time","volume":"10","author":"Laulin","year":"1998","journal-title":"Eur J Neurosci"},{"key":"R66-3-20210204","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00000542-200202000-00025","article-title":"Fentanyl enhancement of carrageenan-induced long-lasting hyperalgesia in rats: prevention by the N-methyl-D-aspartate receptor antagonist ketamine","volume":"96","author":"Rivat","year":"2002","journal-title":"Anesthesiology"},{"key":"R67-3-20210204","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/00000539-200205000-00040","article-title":"The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance","volume":"94","author":"Laulin","year":"2002","journal-title":"Anesth Analg"},{"key":"R68-3-20210204","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00000542-200002000-00029","article-title":"Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine","volume":"92","author":"Celerier","year":"2000","journal-title":"Anesthesiology"},{"key":"R69-3-20210204","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0169-328X(00)00260-6","article-title":"A murine model of opioid-induced hyperalgesia","volume":"86","author":"Li","year":"2001","journal-title":"Brain Res Mol Brain Res"},{"key":"R70-3-20210204","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.neuropharm.2003.08.008","article-title":"Prevention of fentanyl-induced delayed pronociceptive effects in mice lacking the protein kinase Cgamma gene","volume":"46","author":"Celerier","year":"2004","journal-title":"Neuropharmacology"},{"key":"R71-3-20210204","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.pain.2004.04.004","article-title":"Exaggerated nociceptive responses on morphine withdrawal: roles of protein kinase C epsilon and gamma","volume":"110","author":"Sweitzer","year":"2004","journal-title":"Pain"},{"key":"R72-3-20210204","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.1523\/JNEUROSCI.20-18-07074.2000","article-title":"Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance","volume":"20","author":"Vanderah","year":"2000","journal-title":"J Neurosci"},{"key":"R73-3-20210204","first-page":"417","article-title":"The effect of spinal ibuprofen on opioid withdrawal in the rat","volume":"91","author":"Dunbar","year":"2000","journal-title":"Anesth Analg"},{"key":"R74-3-20210204","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1523\/JNEUROSCI.1850-04.2004","article-title":"A role for proinflammatory cytokines and fractalkine in analgesia, tolerance, and subsequent pain facilitation induced by chronic intrathecal morphine","volume":"24","author":"Johnston","year":"2004","journal-title":"J Neurosci"},{"key":"R75-3-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.pain.2006.09.033","article-title":"Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways","volume":"129","author":"Vera-Portocarrero","year":"2007","journal-title":"Pain"},{"key":"R76-3-20210204","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1213\/00000539-200210000-00035","article-title":"Hyperalgesia during opioid abstinence: mediation by glutamate and substance p","volume":"95","author":"Li","year":"2002","journal-title":"Anesth Analg"},{"key":"R77-3-20210204","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0306-4522(02)00452-9","article-title":"Expression of calcitonin gene-related peptide, substance P and protein kinase C in cultured dorsal root ganglion neurons following chronic exposure to mu, delta and kappa opiates","volume":"115","author":"Belanger","year":"2002","journal-title":"Neuroscience"},{"key":"R78-3-20210204","doi-asserted-by":"crossref","first-page":"8312","DOI":"10.1523\/JNEUROSCI.22-18-08312.2002","article-title":"Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity","volume":"22","author":"Mao","year":"2002","journal-title":"J Neurosci"},{"key":"R79-3-20210204","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/neu.20091","article-title":"Antinociceptive and nociceptive actions of opioids","volume":"61","author":"Ossipov","year":"2004","journal-title":"J Neurobiol"},{"key":"R80-3-20210204","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1523\/JNEUROSCI.21-01-00279.2001","article-title":"Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance","volume":"21","author":"Vanderah","year":"2001","journal-title":"J Neurosci"},{"key":"R81-3-20210204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1523\/JNEUROSCI.4054-04.2005","article-title":"Cholecystokinin in the rostral ventromedial medulla mediates opioid-induced hyperalgesia and antinociceptive tolerance","volume":"25","author":"Xie","year":"2005","journal-title":"J Neurosci"},{"key":"R82-3-20210204","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/01.fpc.0000236321.94271.f8","article-title":"Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence","volume":"16","author":"Liang","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"R83-3-20210204","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1172\/JCI118214","article-title":"Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A","volume":"96","author":"Schinkel","year":"1995","journal-title":"J Clin Invest"},{"key":"R84-3-20210204","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1172\/JCI101420","article-title":"The effect of opiates on the pain threshold in post-addicts","volume":"22","author":"Andrews","year":"1943","journal-title":"J Clin Invest"},{"key":"R85-3-20210204","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/00000542-199904000-00013","article-title":"Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia","volume":"90","author":"Joshi","year":"1999","journal-title":"Anesthesiology"},{"key":"R86-3-20210204","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/00000542-199711000-00011","article-title":"Opioid-sparing effects of a low-dose infusion of naloxone in patient-administered morphine sulfate","volume":"87","author":"Gan","year":"1997","journal-title":"Anesthesiology"},{"key":"R87-3-20210204","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0304-3959(01)00425-0","article-title":"The combination of low dose of naloxone and morphine in PCA does not decrease opioid requirements in the postoperative period","volume":"96","author":"Cepeda","year":"2002","journal-title":"Pain"},{"key":"R88-3-20210204","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.pain.2003.09.011","article-title":"Addition of ultralow dose naloxone to postoperative morphine PCA: unchanged analgesia and opioid requirement but decreased incidence of opioid side effects","volume":"107","author":"Cepeda","year":"2004","journal-title":"Pain"},{"key":"R89-3-20210204","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0006-8993(87)91338-2","article-title":"Paradoxical hyperalgesic effect of exceedingly low doses of systemic morphine in an animal model of persistent pain (Freund's adjuvant-induced arthritic rats)","volume":"414","author":"Kayser","year":"1987","journal-title":"Brain Res"},{"key":"R90-3-20210204","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/0006-8993(94)91028-6","article-title":"Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance\/dependence","volume":"636","author":"Shen","year":"1994","journal-title":"Brain Res"},{"key":"R91-3-20210204","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-8993(81)91110-0","article-title":"Dose-dependent analgesic and hyperalgesic effects of systemic naloxone in arthritic rats","volume":"226","author":"Kayser","year":"1981","journal-title":"Brain Res"},{"key":"R92-3-20210204","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/0006-8993(80)90375-3","article-title":"Analgesia and hyperalgesia produced in the rat by intrathecal naloxone","volume":"189","author":"Woolf","year":"1980","journal-title":"Brain Res"},{"key":"R94-3-20210204","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1046\/j.1440-1681.2000.03290.x","article-title":"Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites","volume":"27","author":"Smith","year":"2000","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"R95-3-20210204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0024-3205(01)01133-X","article-title":"Hydromorphone-3-glucuronide: a more potent neuro-excitant than its structural analogue, morphine-3-glucuronide","volume":"69","author":"Wright","year":"2001","journal-title":"Life Sci"},{"key":"R96-3-20210204","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0304-3959(93)90188-U","article-title":"Hyperalgesia and myoclonus in terminal cancer patients treated with continuous intravenous morphine","volume":"55","author":"Sjogren","year":"1993","journal-title":"Pain"},{"key":"R97-3-20210204","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0304-3959(94)90084-1","article-title":"Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists","volume":"59","author":"Sjogren","year":"1994","journal-title":"Pain"},{"key":"R98-3-20210204","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1177\/104990910302000608","article-title":"Morphine hyperalgesia: a case report","volume":"20","author":"Wilson","year":"2003","journal-title":"Am J Hosp Palliat Care"},{"key":"R99-3-20210204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/0304-3959(91)90225-M","article-title":"Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine","volume":"47","author":"De Conno","year":"1991","journal-title":"Pain"},{"key":"R100-3-20210204","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0304-3959(97)00018-3","article-title":"Dose ratio between morphine and hydromorphone in patients with cancer pain: a retrospective study","volume":"72","author":"Lawlor","year":"1997","journal-title":"Pain"},{"key":"R101-3-20210204","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1399-6576.1998.tb05378.x","article-title":"Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories","volume":"42","author":"Sjogren","year":"1998","journal-title":"Acta Anaesthesiol Scand"},{"key":"R102-3-20210204","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.319.7210.627","article-title":"Morphine induced allodynia in a child with brain tumour","volume":"319","author":"Heger","year":"1999","journal-title":"BMJ"},{"key":"R103-3-20210204","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0885-3924(97)00081-X","article-title":"Severe opioid toxicity and somatization of psychosocial distress in a cancer patient with a background of chemical dependence","volume":"13","author":"Lawlor","year":"1997","journal-title":"J Pain Symptom Manage"},{"key":"R104-3-20210204","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1213\/01.ANE.0000068482.67289.1A","article-title":"Allodynia after acute intrathecal morphine administration in a patient with neuropathic pain after spinal cord injury","volume":"97","author":"Parisod","year":"2003","journal-title":"Anesth Analg"},{"key":"R105-3-20210204","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0885-3924(03)00258-6","article-title":"Hyperalgesia: an emerging iatrogenic syndrome","volume":"26","author":"Mercadante","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R106-3-20210204","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/00008506-199704000-00007","article-title":"Hyperalgesia induced by high-dose intrathecal sufentanil in neuropathic pain","volume":"9","author":"Devulder","year":"1997","journal-title":"J Neurosurg Anesthesiol"},{"key":"R107-3-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/104990910502200411","article-title":"Hyperalgesia and opioid switching","volume":"22","author":"Mercadante","year":"2005","journal-title":"Am J Hosp Palliat Care"},{"key":"R108-3-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1017\/S0265021506001700","article-title":"Opioid-induced hyperalgesia","volume":"24","author":"Guntz","year":"2007","journal-title":"Eur J Anaesthesiol"},{"key":"R109-3-20210204","doi-asserted-by":"crossref","first-page":"113","DOI":"10.5055\/jom.2007.0048","article-title":"Using methadone to treat opioid-induced hyperalgesia and refractory pain","volume":"3","author":"Axelrod","year":"2007","journal-title":"J Opioid Manag"},{"key":"R110-3-20210204","first-page":"419","article-title":"Paroxysmal opioid-induced pain and hyperalgesia","volume":"104","author":"Ackerman","year":"2006","journal-title":"J Ky Med Assoc"},{"key":"R112-3-20210204","first-page":"547","article-title":"Successful treatment of hydromorphone-induced neurotoxicity and hyperalgesia","volume":"68","author":"Chung","year":"2004","journal-title":"Conn Med"},{"key":"R113-3-20210204","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/0006-8993(81)90176-1","article-title":"Intrathecal high dose morphine produces hyperalgesia in the rat","volume":"209","author":"Woolf","year":"1981","journal-title":"Brain Res"},{"key":"R114-3-20210204","first-page":"501","article-title":"Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine","volume":"244","author":"Yaksh","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"key":"R115-3-20210204","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1097\/00000542-198605000-00008","article-title":"High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications","volume":"64","author":"Yaksh","year":"1986","journal-title":"Anesthesiology"},{"key":"R116-3-20210204","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0169-328X(01)00332-1","article-title":"Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors","volume":"98","author":"Sakurada","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"key":"R117-3-20210204","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/sj.bjp.0701146","article-title":"Characterization of nociceptin hyperalgesia and allodynia in conscious mice","volume":"121","author":"Hara","year":"1997","journal-title":"Br J Pharmacol"},{"key":"R119-3-20210204","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jpainsymman.2006.09.017","article-title":"A phase III randomized, double-blind, placebo-controlled study evaluating dextromethorphan plus slow-release morphine for chronic cancer pain relief in terminally ill patients","volume":"33","author":"Dudgeon","year":"2007","journal-title":"J Pain Symptom Manage"},{"key":"R120-3-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.pain.2005.03.004","article-title":"MorphiDex (morphine sulfate\/dextromethorphan hydrobromide combination) in the treatment of chronic pain: three multicenter, randomized, double-blind, controlled clinical trials fail to demonstrate enhanced opioid analgesia or reduction in tolerance","volume":"115","author":"Galer","year":"2005","journal-title":"Pain"},{"key":"R122-3-20210204","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1111\/j.1476-5381.1995.tb16660.x","article-title":"Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones","volume":"116","author":"Orser","year":"1995","journal-title":"Br J Pharmacol"},{"key":"R123-3-20210204","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0265021505000803","article-title":"Effects of propofol on N-methyl-D-aspartate receptor-mediated calcium increase in cultured rat cerebrocortical neurons","volume":"22","author":"Grasshoff","year":"2005","journal-title":"Eur J Anaesthesiol"},{"key":"R124-3-20210204","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/00000542-200604000-00021","article-title":"Propofol inhibits phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in neurons","volume":"104","author":"Kingston","year":"2006","journal-title":"Anesthesiology"},{"key":"R125-3-20210204","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1471-4159.2006.03991.x","article-title":"The chemical biology of clinically tolerated NMDA receptor antagonists","volume":"97","author":"Chen","year":"2006","journal-title":"J Neurochem"},{"key":"R126-3-20210204","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00000542-200401000-00022","article-title":"Effects of perioperative oral amantadine on postoperative pain and morphine consumption in patients after radical prostatectomy: results of a preliminary study","volume":"100","author":"Snijdelaar","year":"2004","journal-title":"Anesthesiology"},{"key":"R127-3-20210204","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1016\/S0885-3924(99)00125-6","article-title":"NMDA-receptor antagonists in neuropathic pain: experimental methods to clinical trials","volume":"19","author":"Sang","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R128-3-20210204","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jpain.2006.02.004","article-title":"CHF3381, a N-methyl-D-aspartate receptor antagonist and monoamine oxidase-A inhibitor, attenuates secondary hyperalgesia in a human pain model","volume":"7","author":"Mathiesen","year":"2006","journal-title":"J Pain"},{"key":"R129-3-20210204","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.ejphar.2005.07.004","article-title":"CHF3381, a novel antinociceptive agent, attenuates capsaicin-induced pain in rats","volume":"519","author":"Bassani","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"R130-3-20210204","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1365-2125.2005.02338.x","article-title":"Steady-state pharmacokinetics and pharmacodynamics of CHF3381, a novel antineuropathic pain agent, in healthy subjects","volume":"59","author":"Astruc","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"R131-3-20210204","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0304-3959(01)00455-9","article-title":"Analgesic effects of dextromethorphan and morphine in patients with chronic pain","volume":"96","author":"Heiskanen","year":"2002","journal-title":"Pain"},{"key":"R132-3-20210204","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1213\/00000539-199402000-00002","article-title":"Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia","volume":"78","author":"Tverskoy","year":"1994","journal-title":"Anesth Analg"},{"key":"R133-3-20210204","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3959(99)00096-2","article-title":"Low-dose subcutaneous ketamine infusion and morphine tolerance","volume":"83","author":"Bell","year":"1999","journal-title":"Pain"},{"key":"R134-3-20210204","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0304-3959(01)00278-0","article-title":"\u201cBalanced analgesia\u201d in the perioperative period: is there a place for ketamine?","volume":"92","author":"De Kock","year":"2001","journal-title":"Pain"},{"key":"R135-3-20210204","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/bja\/76.6.829","article-title":"Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans","volume":"76","author":"Ilkjaer","year":"1996","journal-title":"Br J Anaesth"},{"key":"R136-3-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejpain.2007.02.002","article-title":"Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia","volume":"12","author":"Klein","year":"2008","journal-title":"Eur J Pain"},{"key":"R137-3-20210204","first-page":"128","article-title":"Neramexane (merz pharmaceuticals\/forest laboratories)","volume":"9","author":"Rammes","year":"2006","journal-title":"IDrugs"},{"key":"R138-3-20210204","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.clinthera.2006.10.005","article-title":"Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study","volume":"28","author":"Thisted","year":"2006","journal-title":"Clin Ther"},{"key":"R139-3-20210204","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1389450013348489","article-title":"Ifenprodil, a novel NMDA receptor antagonist: site and mechanism of action","volume":"2","author":"Williams","year":"2001","journal-title":"Curr Drug Targets"},{"key":"R140-3-20210204","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0028-3908(98)00218-4","article-title":"Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn","volume":"38","author":"Boyce","year":"1999","journal-title":"Neuropharmacology"},{"key":"R141-3-20210204","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/sj.bjp.0701445","article-title":"Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist","volume":"122","author":"Taniguchi","year":"1997","journal-title":"Br J Pharmacol"},{"key":"R143-3-20210204","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0169-328X(99)00100-X","article-title":"NMDA receptor subunit gene expression in the rat brain: a quantitative analysis of endogenous mRNA levels of NR1Com, NR2A, NR2B, NR2C, NR2D and NR3A","volume":"69","author":"Goebel","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"R144-3-20210204","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/0166-2236(95)93920-S","article-title":"Alternatively spliced isoforms of the NMDARI receptor subunit","volume":"18","author":"Zukin","year":"1995","journal-title":"Trends Neurosci"},{"key":"R145-3-20210204","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09595239600185801","article-title":"Pharmacological properties of ketamine","volume":"15","author":"White","year":"1996","journal-title":"Drug Alcohol Rev"},{"key":"R146-3-20210204","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03011442","article-title":"Ketamine: an update on the first twenty-five years of clinical experience","volume":"36","author":"Reich","year":"1989","journal-title":"Can J Anaesth"},{"key":"R147-3-20210204","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138945005774574533","article-title":"Ketamine: new indications for an old drug","volume":"6","author":"Annetta","year":"2005","journal-title":"Curr Drug Targets"},{"key":"R148-3-20210204","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8537(01)00002-5","article-title":"Anesthetics and the brain","volume":"20","author":"Sloan","year":"2002","journal-title":"Anesthesiol Clin North America"},{"key":"R149-3-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pain.2004.09.036","article-title":"Ketamine and postoperative pain\u2013a quantitative systematic review of randomised trials","volume":"113","author":"Elia","year":"2005","journal-title":"Pain"},{"key":"R150-3-20210204","first-page":"CD004603","article-title":"Perioperative ketamine for acute postoperative pain","author":"Bell","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"R152-3-20210204","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1399-6576.1997.tb04854.x","article-title":"Mapping of punctuate hyperalgesia around a surgical incision demonstrates that ketamine is a powerful suppressor of central sensitization to pain following surgery","volume":"41","author":"Stubhaug","year":"1997","journal-title":"Acta Anaesthesiol Scand"},{"key":"R153-3-20210204","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0885-3924(03)00311-7","article-title":"Ketamine as adjuvant to opioids for cancer pain. A qualitative systematic review","volume":"26","author":"Bell","year":"2003","journal-title":"J Pain Symptom Manage"},{"key":"R155-3-20210204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/00000539-200107000-00042","article-title":"The reversal of fentanyl-induced tolerance by administration of \u201csmall-dose\u201d ketamine","volume":"93","author":"Eilers","year":"2001","journal-title":"Anesth Analg"},{"key":"R156-3-20210204","first-page":"25","article-title":"Rotation to methadone after opioid dose escalation: how should individualization of dosing occur?","volume":"19","author":"Zimmermann","year":"2005","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"R157-3-20210204","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1136\/bmj.306.6876.473","article-title":"Paradoxical pain","volume":"306","author":"Bowsher","year":"1993","journal-title":"BMJ"},{"key":"R158-3-20210204","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pain.2005.06.006","article-title":"Is morphine-3-glucuronide of therapeutic relevance?","volume":"116","author":"Skarke","year":"2005","journal-title":"Pain"},{"key":"R159-3-20210204","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/S0885-3924(99)00129-3","article-title":"MorphiDex (MS:DM) double-blind, multiple-dose studies in chronic pain patients","volume":"19","author":"Katz","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R160-3-20210204","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1016\/S0885-3924(99)00128-1","article-title":"MorphiDex pharmacokinetic studies and single-dose analgesic efficacy studies in patients with postoperative pain","volume":"19","author":"Caruso","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R161-3-20210204","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0885-3924(99)00130-X","article-title":"Morphine with dextromethorphan: conversion from other opioid analgesics","volume":"19","author":"Chevlen","year":"2000","journal-title":"J Pain Symptom Manage"},{"key":"R162-3-20210204","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJM199403033300907","article-title":"Excitatory amino acids as a final common pathway for neurologic disorders","volume":"330","author":"Lipton","year":"1994","journal-title":"N Engl J Med"},{"issue":"1","key":"R163-3-20210204","first-page":"89","article-title":"Drugs and ionic channels: mechanisms and implications","volume":"57","author":"Rang","year":"1981","journal-title":"Postgrad Med J"},{"key":"R164-3-20210204","doi-asserted-by":"crossref","first-page":"4427","DOI":"10.1523\/JNEUROSCI.12-11-04427.1992","article-title":"Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity","volume":"12","author":"Chen","year":"1992","journal-title":"J Neurosci"},{"key":"R165-3-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.1997.sp021909","article-title":"Mechanism of memantine block of NMDA-activated channels in rat retinal ganglion cells: uncompetitive antagonism","volume":"499","author":"Chen","year":"1997","journal-title":"J Physiol"},{"key":"R166-3-20210204","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0166-2236(93)90198-U","article-title":"Prospects for clinically tolerated NMDA antagonists: open-channel blockers and alternative redox states of nitric oxide","volume":"16","author":"Lipton","year":"1993","journal-title":"Trends Neurosci"},{"key":"R167-3-20210204","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/S0306-4522(98)00163-8","article-title":"Neuroprotective concentrations of the N-methyl-D-aspartate open-channel blocker memantine are effective without cytoplasmic vacuolation following post-ischemic administration and do not block maze learning or long-term potentiation","volume":"86","author":"Chen","year":"1998","journal-title":"Neuroscience"},{"key":"R168-3-20210204","first-page":"773","article-title":"Efficacy and tolerability of memantine in patients with dementia syndrome. A double-blind, placebo controlled trial","volume":"41","author":"Ditzler","year":"1991","journal-title":"Arzneimittelforschung"},{"key":"R169-3-20210204","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1056\/NEJMoa013128","article-title":"Memantine in moderate-to-severe Alzheimer's disease","volume":"348","author":"Reisberg","year":"2003","journal-title":"N Engl J Med"},{"key":"R170-3-20210204","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1001\/jama.291.3.317","article-title":"Memantine treatment in patients with moderate to severe Alzheimer disease already receiving donepezil: a randomized controlled trial","volume":"291","author":"Tariot","year":"2004","journal-title":"JAMA"},{"key":"R171-3-20210204","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/archneur.63.1.49","article-title":"A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease","volume":"63","author":"Reisberg","year":"2006","journal-title":"Arch Neurol"},{"key":"R172-3-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(95)11326-R","article-title":"The clinically tested N-methyl-D-aspartate receptor antagonist memantine blocks and reverses thermal hyperalgesia in a rat model of painful mononeuropathy","volume":"187","author":"Eisenberg","year":"1995","journal-title":"Neurosci Lett"},{"key":"R173-3-20210204","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0304-3940(95)11980-B","article-title":"Treatment with the NMDA antagonist memantine attenuates nociceptive responses to mechanical stimulation in neuropathic rats","volume":"198","author":"Carlton","year":"1995","journal-title":"Neurosci Lett"},{"key":"R174-3-20210204","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0022-3565(24)36427-4","article-title":"Efficacy of spinal NMDA receptor antagonism in formalin hyperalgesia and nerve injury evoked allodynia in the rat","volume":"280","author":"Chaplan","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"R175-3-20210204","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/AJP.0b013e31802f67a7","article-title":"Memantine treatment of complex regional pain syndrome: a preliminary report of six cases","volume":"23","author":"Sinis","year":"2007","journal-title":"Clin J Pain"},{"key":"R176-3-20210204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/13550280600873835","article-title":"A placebo-controlled study of memantine for the treatment of human immunodeficiency virus-associated sensory neuropathy","volume":"12","author":"Schifitto","year":"2006","journal-title":"J Neurovirol"},{"key":"R177-3-20210204","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1097\/00000542-200205000-00005","article-title":"Dextromethorphan and memantine in painful diabetic neuropathy and postherpetic neuralgia: efficacy and dose-response trials","volume":"96","author":"Sang","year":"2002","journal-title":"Anesthesiology"},{"key":"R178-3-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S1090-3801(98)90030-1","article-title":"The NMDA (N-methyl-D-aspartate) receptor antagonist memantine in the treatment of postherpetic neuralgia: a double-blind, placebo-controlled study","volume":"2","author":"Eisenberg","year":"1998","journal-title":"Eur J Pain"},{"key":"R179-3-20210204","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1097\/00000539-200010000-00036","article-title":"Memantine (a N-methyl-D-aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double-blinded, cross-over study","volume":"91","author":"Nikolajsen","year":"2000","journal-title":"Anesth Analg"},{"key":"R180-3-20210204","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/S0165-6147(00)01863-0","article-title":"NMDA receptor antagonists as analgesics: focus on the NR2B subtype","volume":"22","author":"Chizh","year":"2001","journal-title":"Trends Pharmacol Sci"},{"key":"R181-3-20210204","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S0306-4522(00)00419-X","article-title":"Localization of N-methyl-D-aspartate NR2B subunits on primary sensory neurons that give rise to small-caliber sciatic nerve fibers in rats","volume":"101","author":"Ma","year":"2000","journal-title":"Neuroscience"},{"key":"R182-3-20210204","first-page":"1619","article-title":"GABAA receptor partially mediated propofol-induced hyperalgesia at superspinal level and analgesia at spinal cord level in rats","volume":"25","author":"Wang","year":"2004","journal-title":"Acta Pharmacol Sin"},{"key":"R183-3-20210204","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1523\/JNEUROSCI.21-05-01750.2001","article-title":"Direct activation of rat spinal dorsal horn neurons by prostaglandin E2","volume":"21","author":"Baba","year":"2001","journal-title":"J Neurosci"},{"key":"R184-3-20210204","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00000542-200602000-00019","article-title":"Increased expression of cyclooxygenase and nitric oxide isoforms, and exaggerated sensitivity to prostaglandin E2, in the rat lumbar spinal cord 3 days after L5-L6 spinal nerve ligation","volume":"104","author":"O'Rielly","year":"2006","journal-title":"Anesthesiology"},{"key":"R185-3-20210204","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1126\/science.1381521","article-title":"Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition","volume":"257","author":"Malmberg","year":"1992","journal-title":"Science"},{"key":"R186-3-20210204","first-page":"89","article-title":"Spinal actions of NSAIDS in blocking spinally mediated hyperalgesia: the role of cyclooxygenase products","volume":"41","author":"Yaksh","year":"1993","journal-title":"Agents Actions Suppl"},{"key":"R187-3-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/sj.bjp.0702587","article-title":"Comparative effects of cyclo-oxygenase and nitric oxide synthase inhibition on the development and reversal of spinal opioid tolerance","volume":"127","author":"Powell","year":"1999","journal-title":"Br J Pharmacol"},{"key":"R188-3-20210204","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/85.5.747","article-title":"Intrathecal cyclooxygenase inhibitor administration attenuates morphine antinociceptive tolerance in rats","volume":"85","author":"Wong","year":"2000","journal-title":"Br J Anaesth"},{"key":"R189-3-20210204","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1097\/00000542-200406000-00029","article-title":"Production of paradoxical sensory hypersensitivity by alpha 2-adrenoreceptor agonists","volume":"100","author":"Quartilho","year":"2004","journal-title":"Anesthesiology"},{"key":"R192-3-20210204","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1054\/jpai.2002.27002","article-title":"Oncology outpatients with pain from bone metastasis require more than around-the-clock dosing of analgesics to achieve adequate pain control","volume":"3","author":"Miaskowski","year":"2002","journal-title":"J Pain"}],"container-title":["The Clinical Journal of Pain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002508-200807000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T18:22:53Z","timestamp":1738261373000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002508-200807000-00003"}},"subtitle":["Molecular Mechanisms and Clinical Considerations"],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":182,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/ajp.0b013e31816b2f43","relation":{},"ISSN":["0749-8047"],"issn-type":[{"value":"0749-8047","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}